Quantcast

Latest Cancer vaccine Stories

2015-03-24 12:32:30

BETHESDA, Md., March 24, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies

2015-03-12 08:33:02

- Duke Cancer Institute researchers publish Phase 1/2 study results in Nature providing human proof-of-concept for new solid tumor target and "immune pre-conditioning" approach to cancer immunotherapy.

2015-03-05 08:32:11

New Therapy Will Harness the Power of Patients' Own Immune Systems to Fight Lung Cancer WASHINGTON, March 5, 2015 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung

2015-03-03 08:35:31

SAN DIEGO, March 3, 2015 /PRNewswire/ -- MabVax Therapeutics (OTCQB: MBVX), a cancer diagnostic and immunotherapy company, announced today that David Hansen, the Company's President and CEO,

2015-02-24 08:34:14

Move puts company in ideal position to attract top scientific and medical talent to advance OncoVAX® clinical trial BALTIMORE, Feb.

2015-02-20 08:26:40

A Follow-On Combination Trial in First-Line Ovarian Cancer in the Neo-Adjuvant Setting Has Been Accepted by FDA LAWRENCEVILLE, N.J., Feb.


Word of the Day
begunk
  • To befool; deceive; balk; jilt.
  • An illusion; a trick; a cheat.
The word 'begunk' may come from a nasalised variant of Scots begeck ("to deceive, disappoint"), equivalent to be- +‎ geck.